Home
Home

APF530

AP Pharma And Ziopharm: The Differences Between Bad News

AP Pharma And Ziopharm: The Differences Between Bad News
Seeking Alpha

AP Pharma's drug for chemo-induced nausea denied approval

AP Pharma's drug for chemo-induced nausea denied approval
Reuters

A.P. Pharma: PDUFA Date On APF530 Looms And I Am A Buyer

A.P. Pharma: PDUFA Date On APF530 Looms And I Am A Buyer
Seeking Alpha

A.P. Pharma Run-Up Trade Into FDA Approval Decision

A.P. Pharma Run-Up Trade Into FDA Approval Decision
TheStreet.com

A.P. Pharma Anticipates FDA Decision On APF530

A.P. Pharma Anticipates FDA Decision On APF530
Seeking Alpha

A.P. Pharma Resubmits New Drug Application for APF530, a Product Candidate for the Prevention of Chemotherapy-Induced Nausea and Vomiting

A.P. Pharma Resubmits New Drug Application for APF530, a Product Candidate for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Yahoo

A.P. Pharma: New Board Member Brings Great Expertise To Possible Launch Of APF530

A.P. Pharma: New Board Member Brings Great Expertise To Possible Launch Of APF530
Seeking Alpha

AP Pharma's APF530 Poised To Return To FDA Review

AP Pharma's APF530 Poised To Return To FDA Review
Seeking Alpha

News

A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
Yahoo
»